Geode Capital Management
AURA icon

Geode Capital Management’s Aura Biosciences AURA Stock Holding History

Geode Capital Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.77M Buy
1,310,862
+55,412
+4% +$318K ﹤0.01% 2456
2025
Q4 		$6.85M Sell
1,255,450
-2,497
-0.2% -$14.8K ﹤0.01% 2597
2025
Q3 		$7.78M Buy
1,257,947
+327,973
+35% +$2.14M ﹤0.01% 2558
2025
Q2 		$5.82M Sell
929,974
-95,582
-9% -$559K ﹤0.01% 2649
2025
Q1 		$6.01M Buy
1,025,556
+12,757
+1% +$96.5K ﹤0.01% 2571
2024
Q4 		$8.33M Buy
1,012,799
+3,972
+0.4% +$37.4K ﹤0.01% 2479
2024
Q3 		$8.99M Buy
1,008,827
+39,379
+4% +$338K ﹤0.01% 2448
2024
Q2 		$7.33M Buy
969,448
+188,258
+24% +$1.38M ﹤0.01% 2511
2024
Q1 		$6.13M Buy
781,190
+105,062
+16% +$871K ﹤0.01% 2581
2023
Q4 		$5.99M Buy
676,128
+149,690
+28% +$1.27M ﹤0.01% 2614
2023
Q3 		$4.72M Buy
526,438
+26,842
+5% +$289K ﹤0.01% 2668
2023
Q2 		$6.17M Buy
499,596
+41,688
+9% +$446K ﹤0.01% 2578
2023
Q1 		$4.25M Buy
457,908
+157,435
+52% +$1.64M ﹤0.01% 2708
2022
Q4 		$3.15M Buy
300,473
+11,161
+4% +$142K ﹤0.01% 2878
2022
Q3 		$5.24M Buy
289,312
+82,018
+40% +$1.24M ﹤0.01% 2647
2022
Q2 		$2.94M Buy
207,294
+101,960
+97% +$1.69M ﹤0.01% 2976
2022
Q1 		$2.32M Buy
105,334
+3,259
+3% +$62.1K ﹤0.01% 3186
2021
Q4 		$1.73M Buy
+102,075
New +$1.82M ﹤0.01% 3440

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management's AURA Position: Q1 2026 in Review

Geode Capital Management increased its Aura Biosciences (AURA) stake by 4.4% in Q1 2026, buying an estimated $318K and bringing the position to 1,310,862 shares worth $8.77M. The position accounts for ﹤0.01% of the portfolio, ranked #2456.

Geode Capital Management first reported a position in AURA in Q4 2021 and has held it in 18 quarters since. The position peaked at $8.99M in Q3 2024. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Geode Capital Management held 1,310,862 shares of Aura Biosciences worth $8.77M as of Q1 2026.
  • Geode Capital Management bought 55,412 Aura Biosciences shares in Q1 2026, an estimated $318K.
  • Aura Biosciences made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #2456 holding.
  • Geode Capital Management first reported a position in Aura Biosciences in Q4 2021 and has held it in 18 quarters since.
  • Geode Capital Management's Aura Biosciences position peaked at $8.99M in Q3 2024.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.